270490
2-丙醇
99.5%, HPLC grade, suitable for HPLC
别名:
IPA, 仲丙醇, 异丙醇
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
(CH3)2CHOH
化学文摘社编号:
分子量:
60.10
UNSPSC Code:
12190000
PubChem Substance ID:
EC Number:
200-661-7
Beilstein/REAXYS Number:
635639
MDL number:
Assay:
99.5%
Grade:
HPLC grade
Technique(s):
HPLC: suitable
Bp:
82 °C (lit.)
Vapor pressure:
33 mmHg ( 20 °C), 44 mmHg ( 25 °C)
产品名称
2-丙醇, 99.5%, HPLC grade
grade
HPLC grade
vapor density
2.1 (vs air)
vapor pressure
33 mmHg ( 20 °C), 44 mmHg ( 25 °C)
assay
99.5%
form
liquid
autoignition temp.
750 °F
purified by
glass distillation
expl. lim.
2.0-12.7 %, 93 °C
technique(s)
HPLC: suitable
impurities
<0.050% water
evapn. residue
<0.0003%
color
colorless
refractive index
n20/D 1.377 (lit.)
bp
82 °C (lit.)
mp
−89.5 °C (lit.)
solubility
water: soluble (completely)
density
0.785 g/mL at 25 °C (lit.)
λ
H2O reference
UV absorption
λ: 205 nm Amax: 1.00, λ: 220 nm Amax: 0.30, λ: 230 nm Amax: 0.15, λ: 245 nm Amax: 0.05, λ: 260 nm Amax: 0.03, λ: 300-400 nm Amax: 0.01
SMILES string
CC(C)O
InChI
1S/C3H8O/c1-3(2)4/h3-4H,1-2H3
InChI key
KFZMGEQAYNKOFK-UHFFFAOYSA-N
Packaging
Still not finding the right product?
Explore all of our products under 2-丙醇
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
53.6 °F - closed cup
flash_point_c
12.0 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
法规信息
新产品
此项目有
Peter C Grayson et al.
Arthritis & rheumatology (Hoboken, N.J.), 67(7), 1922-1932 (2015-04-22)
To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. The source of clinical data and linked biologic specimens was a randomized controlled
Jan Rybniker et al.
Nature communications, 6, 7659-7659 (2015-07-15)
Better antibiotics capable of killing multi-drug-resistant Mycobacterium tuberculosis are urgently needed. Despite extensive drug discovery efforts, only a few promising candidates are on the horizon and alternative screening protocols are required. Here, by testing a panel of FDA-approved drugs in
H Dolatshad et al.
Leukemia, 29(5), 1092-1103 (2014-11-28)
The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted